Efficacy of intracellular immune checkpoint-silenced DC vaccine

Danhong Wang1, Xue F Huang2, Bangxing Hong3

  • 1Department of Hematopoietic Stem Cell Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China.

JCI Insight
|February 9, 2018
PubMed
Abstract

Insights

This study developed a novel genetically modified dendritic cell (gmDC) vaccine for relapsed acute leukemia. The gmDC vaccine demonstrated safety and efficacy, achieving an 83% complete remission rate in relapsed AML patients.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Dendritic cell (DC)-based tumor vaccines have shown limited clinical success.
  • Suppressor of cytokine signaling 1 (SOCS1) inhibits DC immunopotency by regulating inflammatory cytokine signaling.
  • Targeting SOCS1 can enhance DC-mediated anti-tumor immunity.

Purpose of the Study:

  • To develop and evaluate a genetically modified DC (gmDC) vaccine for immunotherapy in patients with relapsed acute leukemia.
  • To assess the safety and efficacy of the gmDC vaccine compared to standard treatment.
  • To investigate the potential of SOCS1-silenced DCs in treating relapsed acute leukemia.

Main Methods:

  • A novel gmDC vaccine (Ad-siSSF) was engineered to deliver tumor-associated antigens (survivin and MUC1), bacterial flagellin, and an RNA interference moiety to suppress SOCS1.
  • A 2-stage phase I clinical trial was conducted in patients with relapsed acute leukemia post-allogeneic hematopoietic stem cell transplantation.
  • Stage 1 compared gmDC treatment (23 patients) with donor lymphocyte infusion (25 patients); Stage 2 evaluated gmDC efficacy in 12 AML patients with early molecular relapse.

Main Results:

  • In vitro, gmDCs induced potent TAA-specific CTL responses.
  • Rhesus monkeys demonstrated the immunostimulatory activity of gmDC vaccination.
  • Stage 1 showed the gmDC vaccine is safe and improves survival in acute leukemia patients.
  • Stage 2 reported an 83% complete remission rate in 12 relapsed AML patients.
  • No grade 3 or 4 graft-versus-host disease was observed in 35 enrolled patients.

Conclusions:

  • Combinatorial modifications in DCs, including SOCS1 silencing, result in a safe and effective gmDC vaccine for relapsed acute leukemia.
  • This approach offers a promising new immunotherapy strategy for hematological malignancies.
  • The study highlights the therapeutic potential of enhancing DC immunopotency through targeted gene modulation.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
51.9K
DC Generator01:19

DC Generator

An alternator converts mechanical energy into electrical energy that varies sinusoidally, resulting in AC current. Meanwhile, a DC generator converts mechanical energy into electrical energy, which are DC pulses with the same polarity. The construction of a DC generator is similar to that of an alternator, except that the pair of slip rings is replaced by a single split ring, also called a commutator. The commutator functions like a periodic rotary switch; it changes the contacts with the...
2.1K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.9K
DC Battery01:21

DC Battery

A conductor needs to be a component of a path that creates a closed loop or full circuit to have a continuous current flowing through it. A current starts to flow if an electric field is created inside an isolated conductor that is not part of a full circuit. The conductor quickly develops a net positive charge at one end and a net negative charge at the other. These charges generate an electric field opposite the direction of the applied electric field, which reduces the current. Eventually,...
1.3K
Self-Efficacy01:29

Self-Efficacy

Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
239
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.8K